Targeting the endocannabinoid system to treat haunting traumatic memories

Frontiers in Behavioral Neuroscience

Volumn , Issue SEP, 2013, Pages

  Akirav, Irit ^a  

^a UNIVERSITY OF HAIFA   (Israel)

Author keywords

Anxiety disorders; Endocannabinoids; Extinction learning; Memory; PTSD rat

Indexed keywords

CANNABIDIOL; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABIS; DRONABINOL; ENDOCANNABINOID; NABILONE;

AMNESIA; ARTICLE; AVOIDANCE BEHAVIOR; COGNITION; EMOTION; HUMAN; MEMORY; MEMORY CONSOLIDATION; MEMORY DISORDER; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; SEX DIFFERENCE;

EID: 84884665824     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2013.00124     Document Type: Article

References (38)

1. Abush, H., and Akirav, I. (2010). Cannabinoids modulate hippocampal memory and plasticity. Hippocampus 20, 1126-1138. doi: 10.1002/hipo.20711
2. Abush, H., and Akirav, I. (2013). Cannabinoids ameliorate impairments induced by chronic stress to synaptic plasticity and short-term memory. Neuropsychopharmacology 38, 521-534. doi: 10.1038/npp.2013.51
3. Atsak, P., Hauer, D., Campolongo, P., Schelling, G., McGaugh, J. L., and Roozendaal, B. (2012a). Glucocorticoids interact with the hippocam-pal endocannabinoid system in impairing retrieval of contextual fear memory. Proc. Natl. Acad. Sci. U.S.A. 109, 3504-3509. doi: 10.1073/pnas.1200742109
4. Atsak, P., Roozendaal, B., and Campolongo, P. (2012b). Role of the endocannabinoid system in regulating glucocorticoid effects on memory for emotional experiences. Neuroscience 204, 104-116. doi: 10.1016/j.neuroscience.2011.08.047
5. Bitencourt, R. M., Pamplona, F. A., and Takahashi, R. N. (2008). Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats. Eur. Neuropsychopharmacol. 18, 849-859. doi: 10.1016/j.euroneuro.2008.07.001
6. Bonn-Miller, M. O., Vujanovic, A. A., and Drescher, K. D. (2011).Cannabis use among military veterans after residential treatment for posttraumatic stress disorder. Psychol. Addict. Behav. 25, 485-491. doi: 10.1037/a0021945
7. Campolongo, P., Morena, M., Scaccianoce, S., Trezza, V., Chiarotti, F., Schelling, G., et al. (2013). Novelty-induced emotional arousal modulates cannabinoid effects on recognition memory and adrenocortical activity. Neuropsychopharmacology 38, 1276-1286. doi: 10.1038/npp.2013.26
8. Campolongo, P., Roozendaal, B., Trezza, V., Hauer, D., Schelling, G., McGaugh, J. L., et al. (2009). Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory. Proc. Natl. Acad. Sci. U.S.A. 106, 4888-4893. doi: 10.1073/pnas.0900835106
9. Campos, A. C., Ferreira, F. R., da Silva, W. A. Jr., and Guimarães, F. S. (2013). Predator threat stress promotes long lasting anxiety-like behaviors and modulates synaptophysin and CB1 receptors expression in brain areas associated with PTSD symptoms. Neurosci. Lett. 533, 34-38. doi: 10.1016/j.neulet.2012.11.016
10. Campos, A. C., Ferreira, F. R., and Guimarães, F. S. (2012). Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: possible involvement of 5HT1A receptors. J. Psychiatr. Res. 46, 1501-1510. doi: 10.1016/j.jpsychires.2012.08.012
11. Chhatwal, J. P., Davis, M., Maguschak, K. A., and Ressler, K. J. (2005). Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear. Neuropsychopharmacology 30, 516-524. doi: 10.1038/sj.npp.1300655
12. Cougle, J. R., Bonn-Miller, M. O., Vujanovic, A. A., Zvolensky, M. J., and Hawkins, K. A. (2011). Posttraumatic stress disorder and cannabis use in a nationally representative sample. Psychol. Addict. Behav. 25, 554-558. doi: 10.1037/a0023076
13. Das, R. K., Kamboj, S. K., Ramadas, M., Yogan, K., Gupta, V., Redman, E., et al. (2013). Cannabidiol enhances consolidation of explicit fear extinction in humans. Psychopharmacology (Berl.) 226, 781-792. doi: 10.1007/s00213-012-2955-y
14. Ehlers, A., Hackmann, A., and Michael, T. (2004). Intrusive re-experiencing in post-traumatic stress disorder: phenomenology, theory, and therapy. Memory 12, 403-415. doi: 10.1080/09658210444000025
15. Fraser, G. A. (2009). The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD). CNS Neurosci. Ther. 15, 84-88. doi: 10.1111/j.1755-5949.2008.00071.x
16. Ganon-Elazar, E., and Akirav, I. (2009). Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance. J. Neurosci. 29, 11078-11088. doi: 10.1523/JNEUROSCI.1223-09.2009
17. Ganon-Elazar, E., and Akirav, I. (2012). Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress. Neuropsychopharmacology 37, 456-466. doi: 10.1038/npp.2011.204
18. Ganon-Elazar, E., and Akirav, I. (2013). Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit. Psychoneuroendocrinology doi: 10.1016/j.psyneuen.2013.01.014. [Epub ahead of print].
19. Haller, J., Bakos, N., Szirmay, M., Ledent, C., and Freund, T. F. (2002). The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety. Eur. J. Neurosci. 16, 1395-1398. doi: 10.1046/j.1460-9568.2002.02192.x
20. Haller, J., Varga, B., Ledent, C., Barna, I., and Freund, T. F. (2004). Context-dependent effects of CB1 cannabinoid gene disruption on anxietylike and social behaviour in mice. Eur. J. Neurosci. 19, 1906-1912. doi: 10.1111/j.1460-9568.2004.03293.x
21. Hauer, D., Ratano, P., Morena, M., Scaccianoce, S., Briegel, I., Palmery, M., et al. (2011). Propofol enhances memory formation via an interaction with the endocannabinoid system. Anesthesiology 114, 1380-1388. doi: 10.1097/ALN.0b013e31821c120e
22. Hauer, D., Schelling, G., Gola, H., Campolongo, P., Morath, J., Roozendaal, B., et al. (2013). Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder. PLoS ONE 8:e62741. doi: 10.1371/journal.pone.0062741
23. Hill, M. N., and Gorzalka, B. B. (2009). The endocannabinoid system and the treatment of mood and anxiety disorders. CNS Neurol. Disord. Drug Targets 8, 451-458. doi: 10.2174/187152709789824624
24. Lutz, B. (2007). The endocannabinoid system and extinction learning. Mol. Neurobiol. 36, 92-101. doi: 10.1007/s12035-007-8004-x
25. Marsicano, G., and Lafenetre, P. (2009). Roles of the endocannabinoid system in learning and memory. Curr. Top. Behav. Neurosci. 1, 201-230. doi: 10.1007/978-3-540-88955-7_8
26. Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., et al. (2002). The endogenous cannabinoid system controls extinction of aversive memories. Nature 418, 530-534. doi: 10.1038/nature00839
27. Moreira, F. A., and Wotjak, C. T. (2010). Cannabinoids and anxiety. Curr. Top. Behav. Neurosci. 2, 429-450. doi: 10.1007/7854_2009_16
28. Myers, K. M., and Davis, M. (2007). Mechanisms of fear extinction. Mol. Psychiatry 12, 120-150. doi: 10.1038/sj.mp.4001939
29. Neumeister, A. (2013). The endocannabinoid system provides an avenue for evidence-based treatment development for PTSD. Depress. Anxiety 30, 93-96. doi: 10.1002/da.22031
30. Neumeister, A., Normandin, M. D., Pietrzak, R. H., Piomelli, D., Zheng, M. Q., Gujarro-Anton, A., et al. (2013). Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. Mol. Psychiatry 18, 1034-1040. doi: 10.1038/mp. 2013.61
31. Niyuhire, F., Varvel, S. A., Martin, B. R., and Lichtman, A. H. (2007). Exposure to marijuana smoke impairs memory retrieval in mice. J. Pharmacol. Exp. Ther. 322, 1067-1075. doi: 10.1124/jpet.107.119594
32. Parolaro, D., Realini, N., Vigano, D., Guidali, C., and Rubino, T. (2010). The endocannabinoid system and psychiatric disorders. Exp. Neurol. 224, 3-14. doi: 10.1016/j.expneurol.2010.03.018
33. Passie, T., Emrich, H. M., Karst, M., Brandt, S. D., and Halpern, J. H. (2012). Mitigation of post-traumatic stress symptoms by Cannabis resin: a review of the clinical and neurobiological evidence. Drug Test. Anal. 4, 649-659. doi: 10.1002/ dta.1377
34. Pitman, R. K. (1989). Post-traumatic stress disorder, hormones, and memory. Biol. Psychiatry 26, 221-223. doi: 10.1016/0006-3223(89)90033-4
35. Potter, C. M., Vujanovic, A. A., Marshall-Berenz, E. C., Bernstein, A., and Bonn-Miller, M. O. (2011). Posttraumatic stress and marijuana use coping motives: the mediating role of distress tolerance. J. Anxiety Disord. 25, 437-443. doi: 10.1016/j.janxdis.2010.11.007
36. Rabinak, C. A., Angstadt, M., Sripada, C. S., Abelson, J. L., Liberzon, I., Milad, M. R., et al. (2013). Cannabinoid facilitation of fear extinction memory recall in humans. Neuropharmacology 64, 396-402. doi: 10.1016/j.neuropharm.2012. 06.063
37. Shalev, A., Roitman, P., and Mechoulam, R. (2013). "Pilot open label trial on oral absorbable A9-THC for chronic PTSD," in Israel Society for Biological Psychiatry abstract book, Hagoshrim, Israel.
38. vanOyen Witvliet, C. (1997). Traumatic intrusive imagery as an emotional memory phenomenon: a review of research and explanatory information processing theories. Clin. Psychol Rev. 17, 509-536. doi: 10.1016/S0272-7358(97) 00025-1